Cargando…

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement

BACKGROUND: Guidelines discourage the use of systemic corticosteroids for atopic dermatitis (AD), but their use remains widespread. OBJECTIVES: To reach consensus among an international group of AD experts on the use of systemic corticosteroids for AD. METHODS: A survey consisting of statements acco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Drucker, A.M., Eyerich, K., de Bruin‐Weller, M.S., Thyssen, J.P., Spuls, P.I., Irvine, A.D., Girolomoni, G., Dhar, S., Flohr, C., Murrell, D.F., Paller, A.S., Guttman‐Yassky, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901393/ https://www.ncbi.nlm.nih.gov/pubmed/28865094 http://dx.doi.org/10.1111/bjd.15928

Ejemplares similares

The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group
por: Alexander, H., et al.
Publicado: (2019)

Conjunctivitis in atopic dermatitis patients with and without dupilumab therapy – international eczema council survey and opinion
por: Thyssen, J.P., et al.
Publicado: (2019)

Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement
por: Leshem, Y.A., et al.
Publicado: (2019)

Human and computational models of atopic dermatitis: A review and perspectives by an expert panel of the International Eczema Council
por: Eyerich, Kilian, et al.
Publicado: (2018)

Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council
por: Silverberg, Jonathan I., et al.
Publicado: (2021)

Priority research questions in atopic dermatitis: an International Eczema Council eDelphi consensus
por: Abuabara, K., et al.
Publicado: (2021)

The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema
por: Vermeulen, F.M., et al.
Publicado: (2020)

TREatment of ATopic eczema (TREAT) Registry Taskforce: consensus on how and when to measure the core dataset for atopic eczema treatment research registries
por: Vermeulen, F.M., et al.
Publicado: (2019)

Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey
por: Drucker, Aaron M., et al.
Publicado: (2022)

TREatment of ATopic eczema (TREAT) Registry Taskforce: an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema photo‐ and systemic therapy registries
por: Gerbens, L.A.A., et al.
Publicado: (2018)

Drugs for the Treatment of Chronic Hand Eczema: Successes and Key Challenges
por: Dubin, Celina, et al.
Publicado: (2020)

Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology
por: Paller, Amy S, et al.
Publicado: (2020)

TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries
por: Gerbens, Louise A. A., et al.
Publicado: (2017)

Measurement properties of quality of life measurement instruments for infants, children and adolescents with eczema: protocol for a systematic review
por: Heinl, Daniel, et al.
Publicado: (2016)

Diagnosis and Management of Pediatric Chronic Hand Eczema: The PeDRA CACHES Survey
por: Haft, Michael A., et al.
Publicado: (2023)

Changes to the European Resuscitation Council guidelines for adult resuscitation
por: Kane, A.D., et al.
Publicado: (2022)

Effect of dupilumab on hand eczema in patients with atopic dermatitis: An observational study
por: Oosterhaven, Jart A.F., et al.
Publicado: (2019)

Eczema and subsequent suicide: a matched case–control study
por: Drucker, Aaron Mark, et al.
Publicado: (2018)

Development and initial testing of a new instrument to measure the experience of eczema control in adults and children: Recap of atopic eczema (RECAP)
por: Howells, L.M., et al.
Publicado: (2020)

Mapping exercise and status update of eight established registries within the TREatment of ATopic eczema Registry Taskforce
por: Bosma, Angela L., et al.
Publicado: (2022)

Therapeutic education in atopic dermatitis: A position paper from the International Eczema Council
por: Eichenfield, Lawrence F., et al.
Publicado: (2021)

Achieving consensus over the assessment of clinical signs in eczema trials
por: Thomas, Kim S, et al.
Publicado: (2015)

Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
por: Howells, L., et al.
Publicado: (2019)

Hyperkeratotic hand eczema: Eczema or not?
por: Politiek, Klaziena, et al.
Publicado: (2020)

Translating translation into patient benefit for atopic eczema
por: Reynolds, N.J., et al.
Publicado: (2016)

Treatment of moderate‐to‐severe atopic eczema in adults within the U.K.: results of a national survey of dermatologists
por: Taylor, K., et al.
Publicado: (2017)

Do patient characteristics matter when calculating sample size for eczema clinical trials?
por: Howells, L., et al.
Publicado: (2021)

Economic Burden of Chronic Hand Eczema: A Review
por: Armstrong, April, et al.
Publicado: (2022)

The long‐term effect of dupilumab on chronic hand eczema in patients with moderate to severe atopic dermatitis—52 week results from the Dutch BioDay Registry
por: Voorberg, Angelique N., et al.
Publicado: (2022)

Proposed Statement by the CERN Council
Publicado: (1957)

Statement to the Council by the Director-General
Publicado: (1962)

A comparison between self‐reported hand eczema and self‐reported signs and symptoms of skin lesions indicating hand eczema
por: Yüksel, Yasemin Topal, et al.
Publicado: (2022)

Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial
por: Guttman-Yassky, Emma, et al.
Publicado: (2020)

Eczema
Publicado: (1891)

Eczema
Publicado: (1890)

Eczema
Publicado: (1880)

Eczema
por: Steinrauf, Wm.
Publicado: (1890)

Immune Pathways in Atopic Dermatitis, and Definition of Biomarkers through Broad and Targeted Therapeutics
por: Mansouri, Yasaman, et al.
Publicado: (2015)

Successful use of ustekinumab therapy in refractory severe atopic dermatitis
por: Shroff, Anjali, et al.
Publicado: (2014)

A possible role for IL-17A in establishing Th2 inflammation in murine models of atopic dermatitis
por: Dhingra, Nikhil, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_11ohb69huimfcqmotsfblk2l16